Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Jun. 30, 2013	Jul. 01, 2012
Cash flows from operating activities:
Net loss	$ (15,743,000)	$ (12,638,000)
Add: loss (income) from discontinued operations (net of $0 tax)	3,072,000	(3,872,000)
Loss from continuing operations	(12,671,000)	(16,510,000)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization	254,000	34,000
Non-cash interest expense	8,516,000	4,003,000
(Gain) loss from changes in fair value of derivative liability	(8,885,000)	4,419,000
Common stock and warrants issued to pay operating expenses	183,000
Non-cash stock-based compensation	453,000	471,000
(Increase) in accounts receivable	(127,000)
(Increase) in prepaid expenses and other assets	(138,000)	(136,000)
Increase in accounts payable and accrued expenses	1,638,000	1,164,000
Increase (decrease) in Executive Salary Continuation Plan liability	(1,000)	19,000
Increase in deferred revenue	115,000
Net cash used in operating activities	(10,663,000)	(6,536,000)
Cash flows from investing activities:
Property and equipment expenditures	(152,000)	(98,000)
Increase in note receivable from sale of fixed assets	(200,000)
Proceeds from sale of Thermal Imaging Business	1,200,000
Net cash paid related to acquisition of Bivio	(569,000)
Net cash provided by (used in) investing activities	279,000	(98,000)
Cash flows from financing activities
Proceeds from issuances of debt	10,770,000
Proceeds from revolving credit line		5,000,000
Proceeds from options and warrants exercised	103,000	246,000
Debt issuance costs paid	(209,000)	(143,000)
Principal payments of notes payable and settlement agreements	(13,000)	(2,727,000)
Principal payments of capital leases	(13,000)	(10,000)
Net cash provided by financing activities	10,638,000	2,366,000
Cash flows from discontinued operations:
Net cash used in operating activities	(1,702,000)	(3,005,000)
Net cash used in investing activities	62,000	8,198,000
Net cash provided by (used) in discontinued operations	(1,640,000)	5,193,000
Effect of foreign currency translation	(206,000)
Net increase (decrease) in cash and cash equivalents	(1,592,000)	925,000
Cash and cash equivalents at beginning of period	1,738,000	2,735,000
Cash and cash equivalents at end of period	146,000	3,660,000
Non-cash investing and financing activities:
Non-cash conversion of preferred stock to common stock	60,000	785,000
Conversion of Subordinated Secured Convertible Promissory Notes and accrued interest to common stock	30,000
Non-cash conversion of 2012 Notes to 2013 Notes, including paid in kind interest	5,571,000
Common stock issued to pay accrued interest and board fees	1,444,000	991,000
Issuance of warrants to acquire Bivio Software assets	85,000
Senior Subordinated Note issued to settle accrued interest	291,000	394,000
Warrants issued to lending institutions	1,148,000	432,000
Supplemental cash flow information:
Cash paid for interest	455,000	427,000
Cash paid for income taxes	$ 3,000	$ 3,000